Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Mitchell
Conference
HD Repair Forum
The HD Repair Forum is dedicated to serving those involved in the collision repair work of
Workers' Comp
Article
The Rise of Fentanyl in the Midst of an Already Troubling Opioid Epidemic
Each day we hear more and more stories of addiction, overdose, and deaths with heartbreaking stories of the individuals and the families who have b
The Fintech Times
Article
Insurtech Innovations in Tech with EvolutionIQ, CoTé, Genex Services, Kinetic Insurance
Shahin Hatamian, senior vice president of product management at Mitchell, believes the use of data and analytics have seen major innovation in the
ASIA
Conference
Alabama Self-Insured Association
MWCEA
Conference
Maryland Workers’ Compensation Educational Association
Mitchell
News Release
Mitchell Diagnostics Platform Surpasses 30,000 ADAS Calibrations
Demand continues to grow for company’s Diagnostics as a Service (DaaS) solutions designed to help collision repairers efficiently perform cali